Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-08 Sale |
2025-01-10 4:30 pm |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
13,673 | $8.2182 | $112,367 | 124,207 (Direct) |
View |
| 2025-01-08 Sale |
2025-01-10 4:30 pm |
Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks |
9,971 | $8.2182 | $81,944 | 52,549 (Direct) |
View |
| 2025-01-08 Sale |
2025-01-10 4:30 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
21,172 | $8.2182 | $173,996 | 273,616 (Direct) |
View |
| 2025-01-08 Sale |
2025-01-10 4:30 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
14,545 | $8.2182 | $119,534 | 111,112 (Direct) |
View |
| 2025-01-08 Sale |
2025-01-10 4:30 pm |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
10,799 | $8.2183 | $88,749 | 89,748 (Direct) |
View |
| 2024-12-16 Purchase |
2024-12-18 4:11 pm |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
1,250,000 | $6 | $7,500,000 | 2,984,752 (Indirect Direct) |
View |
| 2024-11-29 Sale |
2024-12-03 5:48 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
20,392 | $4.5556 | $92,898 | 125,657 (Direct) |
View |
| 2024-11-29 Sale |
2024-12-03 5:48 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
48,847 | $4.5556 | $222,527 | 294,788 (Direct) |
View |
| 2024-11-29 Sale |
2024-12-03 5:47 pm |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
13,935 | $4.5556 | $63,482 | 100,547 (Direct) |
View |
| 2024-11-29 Sale |
2024-12-03 5:46 pm |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
22,081 | $4.5556 | $100,592 | 137,880 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 08:31 am |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
14,851 | $6.4726 | $96,125 | 146,049 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 08:29 am |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
22,528 | $6.4726 | $145,815 | 330,735 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 08:28 am |
Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks |
9,884 | $6.4726 | $63,975 | 62,520 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 08:26 am |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
10,875 | $6.4726 | $70,390 | 114,482 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 08:24 am |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
14,051 | $6.4726 | $90,947 | 159,961 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 08:36 am |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
13,330 | $5.9734 | $79,625 | 160,900 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 08:35 am |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
20,293 | $5.9734 | $121,218 | 353,263 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 08:34 am |
Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks |
8,897 | $5.9734 | $53,145 | 72,404 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 08:32 am |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
9,769 | $5.9734 | $58,354 | 125,357 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 08:30 am |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
12,645 | $5.9734 | $75,534 | 174,012 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-21 Exercise |
2024-11-21 3:07 pm |
N/A 2030-10-10 |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
12,900 | $0 | 2,107,603 (Direct) |
View |
| 2024-11-21 Exercise |
2024-11-21 3:07 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
12,900 | $1.55 | 2,107,603 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:41 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | PAPA JOSEPH C Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:40 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Nguyen Diem Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:39 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Nabel Gary J. Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:39 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:37 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:36 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Loggia Nicoletta Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:35 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Gaeta Renee Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:34 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Benz Edward J. JR Director |
14,240 | $0 | 14,240 (Direct) |
View |
Ownership |
2024-01-19 08:30 am |
N/A N/A |
Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks |
0 | $0 | 145,799 (Direct) |
View |